Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
1.945
+0.005 (0.26%)
Jul 30, 2026, 2:58 PM EDT - Market open
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $350.27 million as of July 30, 2026. Its market cap has decreased by -20.09% in one year.
Market Cap
350.27M
Enterprise Value
163.57M
1-Year Change
-20.09%
Ranking
Category
Stock Price
$1.95
ChartMarket Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has decreased from $435.34M to $350.27M, a decrease of -19.54%. That is a compound annual growth rate of -4.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 350.27M | -63.33% |
| Dec 31, 2025 | 955.12M | 378.75% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
| Apr 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Century Therapeutics | 364.32M |
| Enanta Pharmaceuticals | 362.03M |
| Abeona Therapeutics | 355.08M |
| Upstream Bio | 348.83M |
| Rocket Pharmaceuticals | 342.87M |
| DiaMedica Therapeutics | 340.54M |
| Palisade Bio | 340.22M |
| Lexeo Therapeutics | 338.43M |